Literature DB >> 12170942

Artemether vs quinine therapy in Plasmodium falciparum malaria in Manipur--a preliminary report.

N B Singh1, S Bhagyabati Devi, T B Singh, M A Singh, N B Singh1.   

Abstract

Qinghaosu and its derivatives are rapidly effective antimalarial drugs derived from a Chinese plant (sweet worm wood). Preliminary studies suggest that these drugs may be more effective than quinine in the treatment of Plasmodium falciparum malaria. A randomised double blind trial was conducted in 52 cases of Plasmodium falciparum malaria cases. In all 26 cases were given artemether and another 26 were given quinine. There were 2 (7.5%) deaths in artemether group and 4 (15%) deaths in quinine group. The parasites were cleared more quickly from the blood in artemether group when compared to quinine group (mean-72 hrs vs 96 hrs). Resolution of fever was comparable in both artemether and quinine group (mean-84 hrs vs 78 hrs) and also the average time of recovery from coma was more earlier in artemether group (mean-60 hrs vs 72 hrs). The only side effect noticed with artemether therapy was gastrointestinal (GI) intolerance while quinine therapy was associated with myocarditis, hypotension, hypoglycemia and GI intolerance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12170942

Source DB:  PubMed          Journal:  J Commun Dis        ISSN: 0019-5138


  3 in total

Review 1.  Malaria: severe, life-threatening.

Authors:  Susanne Helena Sheehy; Brian John Angus
Journal:  BMJ Clin Evid       Date:  2011-03-07

Review 2.  Malaria: severe, life-threatening.

Authors:  Aika Amy Anita Omari; Paul Garner
Journal:  BMJ Clin Evid       Date:  2007-07-01

3.  Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adults.

Authors:  Pauline Byakika-Kibwika; Mohammed Lamorde; Jonathan Mayito; Lillian Nabukeera; Harriet Mayanja-Kizza; Elly Katabira; Warunee Hanpithakpong; Celestino Obua; Nadine Pakker; Niklas Lindegardh; Joel Tarning; Peter J de Vries; Concepta Merry
Journal:  Malar J       Date:  2012-04-27       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.